Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Varela, Rosario
DOB:	03-MAY-1956 (Age: 69)
Gender:	male
Address:	Ronda de Graciela Llorens 62 46001 Valencia (Spain)
ID:	8295-992682-3 (ECI)

Report
Date:	14-NOV-2015

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Centro Privado de Educación Especial Parálisis Cerebral Infantil Calle Alboraya 4 46010 Valencia (Spain)

Specimen
Collected:	14-NOV-2015

Chemistry

Test	14-NOV-2015	Reference Range	Unit
Glucose [Mass/volume] in Blood	98.3	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	12.5	7 - 18	mg/dL
Creatinine [Mass/volume] in Blood	3.2 H	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.6	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	139.5	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.0	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	104.5	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	25.9	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	6.7	6.6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	4.3	3.5 - 5.5	g/dL
Globulin [Mass/volume] in Serum by calculation	2.7 L	20 - 39	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	1.0	0.2 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	27.1 L	39 - 117	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	43.5 H	10 - 40	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	27.5	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	155.1	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	197.2 H	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	102.1 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	78.2 H	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significantly elevated creatinine, suggesting impaired renal function. Mildly elevated ALT may indicate some liver involvement. Lipid profile reveals high triglycerides, LDL, and HDL. Low globulin and alkaline phosphatase are noted but of unclear clinical significance. Other parameters are within normal limits. Recommend further evaluation of renal function and cardiovascular risk, and correlation with clinical findings.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows significantly elevated creatinine, suggesting impaired renal function. Mildly elevated ALT may indicate some liver involvement. Lipid profile reveals high triglycerides, LDL, and HDL. Low globulin and alkaline phosphatase are noted but of unclear clinical significance. Other parameters are within normal limits. Recommend further evaluation of renal function and cardiovascular risk, and correlation with clinical findings.